Bharat Biotech ‘inadvertently missed’ including ICMR, NIV as co-developers in Covaxin patent: Centre

Scroll Staff

· Aug 03, 2024 · 06:58 pm

‘Inadvertent mistake,’ says Bharat Biotech on why it failed to credit ICMR in Covaxin patent filings

Scroll Staff

· Jun 23, 2024 · 11:05 am

ICMR demands international journal withdraw study by Indian researchers on safety of Covaxin

Scroll Staff

· May 20, 2024 · 02:56 pm

Covaxin has ‘excellent track record’, says Bharat Biotech after study details side effects

Scroll Staff

· May 18, 2024 · 12:33 pm

Covaxin maker Bharat Biotech, linked firms gave Rs 25 crore to TDP even though it is out of power

Anjana Meenakshi Project Electoral Bond

· Mar 24, 2024 · 08:00 am

Coronavirus: Mansukh Mandaviya launches India’s first intranasal vaccine

Scroll Staff

· Jan 26, 2023 · 05:03 pm

Covid-19: Bharat Biotech to launch intranasal vaccine on January 26

Scroll Staff

· Jan 21, 2023 · 08:40 pm

Covid-19: Bharat Biotech’s intranasal vaccine gets emergency use approval

Scroll Staff

· Sep 06, 2022 · 05:26 pm

Coronavirus: Bharat Biotech says its intranasal vaccine is safe, generates immune response

Scroll Staff

· Aug 15, 2022 · 05:54 pm

Bharat Biotech must address WHO suspension on procuring Covaxin through UN, says foreign ministry

Scroll Staff

· Apr 29, 2022 · 09:19 am

WHO suspends Covaxin supply through United Nations agencies citing manufacturing deficiencies

Scroll Staff

· Apr 03, 2022 · 10:47 am

The big news: Nawab Malik sent to ED custody till March 3, and nine other top stories

Scroll Staff

· Feb 23, 2022 · 11:15 pm

‘The Wire’ says Bharat Biotech did not serve notice before filing defamation case

Scroll Staff

· Feb 23, 2022 · 11:01 pm

The big news: Kerala reports more than 54,000 Covid cases, and nine other top stories

Scroll Staff

· Jan 28, 2022 · 08:02 pm

Bharat Biotech gets approval to conduct trials for its intranasal Covid-19 booster dose

Scroll Staff

· Jan 28, 2022 · 03:20 pm

Covaxin booster dose neutralises both Delta and Omicron variants, says Bharat Biotech

Scroll Staff

· Jan 13, 2022 · 08:19 am

No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose

Scroll Staff

· Jan 09, 2022 · 08:22 am

Covaxin has shown good immune response among children, says Covid panel chief

Scroll Staff

· Dec 27, 2021 · 10:04 am

Covaxin receives DCGI approval for use in children from 12 to 18 years

Scroll Staff

· Dec 26, 2021 · 08:15 am

Covaxin shows 50% efficacy against symptomatic cases of coronavirus: Lancet study

Scroll Staff

· Nov 24, 2021 · 07:17 am